An In Vivo CRISPR Screen Identifies That SNRPC Promotes Triple-Negative Breast Cancer Progression

To identify oncogenic RNA-binding proteins in TNBC, researchers employed an in vivo CRISPR screen and a TNBC progression model, which revealed small nuclear ribonucleoprotein polypeptide C (SNRPC) as a key modulator of TNBC progression.